Biofrontera Inc. (BFRIW) stock
BFRIWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BFRI
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.00+0.00 (0.00%)
Close on Oct 30, 2026Market cap $12.96MP/E –Yield –
Biofrontera total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Biofrontera's total debt was $296.00K at Jun 30, 2024. For fiscal 2023 it was $3.90M.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $3.90M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2024 | Jun 30, 2024 | $296.00K | – |
| Q1 FY2024 | Mar 31, 2024 | $2.36M | – |
| Q4 FY2023 | Dec 31, 2023 | $3.90M | – |